Delayed Amnesic Syndrome after Riluzole Use in Major Depressive Disorder: A Case Report

被引：0
|
作者：
Cardoos, Amber [1 ]
Inamori, Aya [1 ]
Sanacora, Gerard [2 ]
Fava, Maurizio [1 ]
Mischoulon, David [1 ]
机构：
[1] Massachusetts Gen Hosp, Dept Psychiat, Depress Clin & Res Program, Boston, MA 02114 USA
[2] Yale Univ, Clin Neurosci Res Unit, Dept Psychiat, Sch Med, New Haven, CT USA
来源：
PSYCHOSOMATICS | 2013年 / 54卷 / 05期
关键词：
OPEN-LABEL TRIAL; SERUM CONCENTRATIONS; METABOLISM; RECEPTORS; SYMPTOMS; DISEASE; NMDA; MICE; ALS;
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：488 / 492
页数：5
相关论文
共 50 条
  • [41] EFFICACY AND LONG-TERM CLINICAL OUTCOME OF COMORBID POSTTRAUMATIC STRESS DISORDER AND MAJOR DEPRESSIVE DISORDER AFTER ELECTROCONVULSIVE THERAPY
    Ahmadi, Naser
    Moss, Lori
    Simon, Edwin
    Nemeroff, Charles B.
    Atre-Vaidya, Nutan
    DEPRESSION AND ANXIETY, 2016, 33 (07) : 640 - 647
  • [42] Vortioxetine vs. Other Antidepressants in Patients with Major Depressive Episode With or Without Substance Use Disorder
    Kotzalidis, Georgios D.
    Lombardozzi, Ginevra
    Matrone, Marta
    Amici, Emanuela
    Perrini, Filippo
    Cuomo, Ilaria
    De Filippis, Sergio
    CURRENT NEUROPHARMACOLOGY, 2021, 19 (12) : 2296 - 2307
  • [43] Cerebellar Cognitive Affective Syndrome and Delusional Disorder Associated With Long-Term Phenytoin Use A Case Report
    Malali Metin, Hulya
    Aksu, Taner
    Akyildiz, Utku Ogan
    Sevincok, Levent
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2023, 43 (02) : 184 - 186
  • [44] Negative impact of migraine on quality of life after 4 weeks of treatment in patients with major depressive disorder
    Hung, Ching-I
    Liu, Chia-Yih
    Yang, Ching-Hui
    Wang, Shuu-Jiun
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2012, 66 (01) : 8 - 16
  • [45] Anterior Insula Volume and Guilt Neurobehavioral Markers of Recurrence After Early Childhood Major Depressive Disorder
    Belden, Andy C.
    Barch, Deanna M.
    Oakberg, Timothy J.
    April, LauraM.
    Harms, Michael P.
    Botteron, Kelly N.
    Luby, Joan L.
    JAMA PSYCHIATRY, 2015, 72 (01) : 40 - 48
  • [46] Default Mode Connectivity in Major Depressive Disorder Measured Up to 10 Days After Ketamine Administration
    Evans, Jennifer W.
    Szczepanik, Joanna
    Brutsche, Nancy
    Park, Lawrence T.
    Nugent, Allison C.
    Zarate, Carlos A., Jr.
    BIOLOGICAL PSYCHIATRY, 2018, 84 (08) : 582 - 590
  • [47] Clinical experiences with intranasal esketamine for major depressive disorder resistant to treatment and with a psychiatric emergency: case presentations
    Pompili, Maurizio
    Sarli, Giuseppe
    Erbuto, Denise
    Manfredi, Giovanni
    Comparelli, Anna
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2023, 38 (03) : 195 - 200
  • [48] Use of bevacizumab (Avastin®) in KID syndrome: case report
    Caye, Luiza
    Scheid, Karin
    Dal Pizzol, Melissa Manfroi
    Freda, Roberto
    ARQUIVOS BRASILEIROS DE OFTALMOLOGIA, 2010, 73 (03) : 285 - 287
  • [49] Fasting serum leptin levels in elderly women with major depressive disorder: a case-control study
    Szczepocka, Ewa
    Lucka, Anna
    Wysokinski, Adam
    NEUROENDOCRINOLOGY LETTERS, 2019, 40 (01) : 51 - 57
  • [50] An Open-Label Pilot Study of Duloxetine in Patients With Irritable Bowel Syndrome and Comorbid Major Depressive Disorder
    Lewis-Fernandez, Roberto
    Lam, Peter
    Lucak, Susan
    Galfalvy, Hanga
    Jackson, Elizabeth
    Fried, Jane
    Rosario, Melissa
    de la Cruz, Ana Alicia
    Sanchez-Lacay, Arturo
    Diaz, Samantha
    Schneier, Franklin
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2016, 36 (06) : 710 - 715
12345